Historical record - last NADAC effective date: 10/18/2023
Product Information
TETRACYCLINE 500 MG CAPSULE is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.9294 per EA under NDC 23155001801. Its NADAC has been published 499 times since Apr 23, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the tetracycline hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155001801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/18/2023
Active Ingredients
TETRACYCLINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA050278FDA Approved
Before 1982
TE Code
AB
On Market Since
9/15/2024
Pharmacological Classes
Price Statistics
The NADAC for TETRACYCLINE 500 MG CAPSULE has been published 499 times since Apr 23, 2014, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9294 per EA |
|---|---|
| All-time high | $11.1790 (Apr 13, 2016) |
| All-time low | $0.6919 (Jan 18, 2023) |
| Median price | $3.2122 |
| Average price | $4.8409 |
| Largest weekly change | +103.4% (Dec 22, 2021) |
| Weeks tracked | 499 |
| Tracking since | Apr 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-6.8%
5Y
-43.4%
All
-89.4%
Last surveyed Nov 8, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TETRACYCLINE 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 500 MG CAPSULE, manufactured by Heritage Pharmaceuticals Inc., is $0.9294 per EA (NDC 23155001801), effective Nov 8, 2023.
How has the price of TETRACYCLINE 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TETRACYCLINE 500 MG CAPSULE has declined 89.4%. It has been tracked across 499 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for TETRACYCLINE 500 MG CAPSULE?
Since Apr 23, 2014, the NADAC for TETRACYCLINE 500 MG CAPSULE has ranged from a low of $0.6919 (Jan 18, 2023) to a high of $11.1790 (Apr 13, 2016), with a median of $3.2122 per EA.
Are there cheaper alternatives to TETRACYCLINE 500 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TETRACYCLINE 500 MG CAPSULE, is $0.5721 per EA — about 38% below TETRACYCLINE 500 MG CAPSULE.
Who manufactures TETRACYCLINE 500 MG CAPSULE?
TETRACYCLINE 500 MG CAPSULE (NDC 23155001801) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.